(IN BRIEF) Scientists at the MRC-University of Glasgow Centre for Virus Research and the University of Sydney have utilized advanced AI technologies, specifically AlphaFold and ESMFold, to map the protein structures of numerous viruses from the Flaviviridae family, which includes … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged AI, AlphaFold, Dengue, Dr. Joe Grove, ESMFold, hepatitis C, partnership, sustainability, University of Glasgow, University of Sydney, vaccine development, Viral Protein Structures, ZIKA
(IN BRIEF) Unitaid has allocated over £6 million in new funding to the University of Liverpool-led LONGEVITY project, aimed at enhancing long-acting therapeutics for tuberculosis, malaria, and hepatitis C. Started in 2020, the project has achieved preclinical milestones for long-acting … Read the full press release
Posted in Business, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Non Profit, Science, Switzerland, Technology, United Kingdom
Tagged hepatitis C, Infectious Disease Therapeutics, LONGEVITY Project, malaria, partnership, Professor Andrew Owen, Professor Louise Kenny, Professor Steve Rannard, Professor Tariq Ali, Professor Wiebe Van Der Hoek, sustainability, Switzerland, tuberculosis, UNITAID, University of Liverpool
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
